The TOUCH program and risk management plan for the administration of Natalizumab: Updated safety results from the use of Natalizumab in patients with relapsing Multiple Sclerosis and Crohnʼs Disease | Zendy

AI Assistant Blog Pricing

The TOUCH program and risk management plan for the administration of Natalizumab: Updated safety results from the use of Natalizumab in patients with relapsing Multiple Sclerosis and Crohnʼs Disease

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.